New Video on Plasma Donation Available Viewers travel through the steps of becoming a donor and learn about their importance in producing lifesaving therapies
ANNAPOLIS, Md., Jan. 28, 2011 /PRNewswire/ -- Anyone curious about what to expect as a plasma donor and how plasma contributes to lifesaving medicines can now learn about the process thanks to a new DVD from the Plasma Protein Therapeutics Association (PPTA). "Becoming a Plasma Donor," details the safety and eligibility steps required to become a committed plasma donor at one of the 400-plus U.S. Food and Drug Administration-licensed and International Quality Plasma Program-certified plasma collection centers in the United States. The 10 minute video illustrates how critically important plasma donors are to the production of safe and effective therapies that help individuals coping with rare, chronic, life-threatening diseases.
PPTA's DVD guides viewers step-by-step through the process that a new plasma donor experiences when applying to donate plasma, from the completion and review of the health history questionnaire to the physical examination to the donation process itself.
"I'm pleased to announce this new resource, which gives people who are interested in donating plasma important information on the plasma donation process and shows viewers what they can expect," said PPTA President and CEO Jan M. Bult.
Plasma protein therapies are used to treat life-threatening, rare, chronic diseases and disorders such as hemophilia, primary immunodeficiencies, alpha-1 antitrypsin deficiency and neurological and autoimmune disorders. In addition, plasma protein therapies are used to treat other serious medical conditions such as shock, trauma, and burns.
"A major goal of PPTA is to help promote the understanding of and access to safe and effective plasma protein therapeutics for all patients in the world," said Bult. "This DVD is an educational tool that showcases the numerous safety measures in place to protect the health of the donor and the patients who rely on therapies made from plasma."
The International Quality Plasma Program (IQPP) is a voluntary industry certification that complements the regulatory requirements of U.S. and international government authorities that govern the collection of source plasma used to manufacture therapies. The achievement of certification illustrates the industry's ongoing commitment to quality and safety.
To view the DVD online, please go to: http://www.pptaglobal.org/news/videos/plasma-donation.aspx. To obtain a copy of the new DVD, please contact Diana Krueger at email@example.com or (443) 433-1107. For more information on the video or the plasma protein therapeutics industry, please contact Kara Flynn at (443) 458-4669 or Kym H. Kilbourne at (443) 458-4682.
The Plasma Protein Therapeutics Association (PPTA) represents the world's leading manufacturers of plasma-derived and recombinant biological therapies, collectively known as plasma protein therapies. These critical therapies are infused or injected by more than 1 million people worldwide to treat a variety of rare, life threatening diseases and serious medical conditions. PPTA members produce in excess of 80 percent of the plasma protein therapies used in the United States today and more than 60 percent worldwide. The manufacturer membership of PPTA in the United States currently includes Baxter, Biotest, Cangene, CSL Behring, Grifols, and Talecris. PPTA is a global trade association that administers international, voluntary standards programs to help ensure the highest quality and safety of plasma protein therapies and the plasma collected to manufacture them. Additionally, PPTA works in partnership with the patient community and consumer advocates to help ensure continued access to lifesaving plasma protein therapies.
SOURCE Plasma Protein Therapeutics Association (PPTA)